Capital Flow Monitor · Sponsors · CIK 2029039
Nasus Pharma Ltd
34 YITZHAK SADEH ST, TEL AVIV, L3, 6274711 · +972.3.573.6632
Biotechnology · Corporation· inc. ISRAEL true
Fit score
—
Offering
$15.0M
Sold
$15.0M
% sold
100.0%
Investors
15
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-25 | D ·current | 506(b) | $15.0M | $15.0M | 100.0% | 15 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Dan Teleman — Executive Officer / Director, TEL AVIV, L3
- Eyal Rubin — Executive Officer, TEL AVIV, L3
- Udi Gilboa — Director, TEL AVIV, L3
- Dalia Megiddo — Executive Officer / Director, TEL AVIV, L3
- Ronnie Hershman — Director, TEL AVIV, L3
- David Silberman — Director, TEL AVIV, L3
- Sharon Shacham — Director, TEL AVIV, L3
- Isaac Israel — Director, TEL AVIV, L3
Placement agents
- Laidlaw & Company (uk) Ltd · 0 RE raises
- Citizens Jmp Securities, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.